Giselle V Ripoll Selected Research

Deamino Arginine Vasopressin (Desmopressin)

10/2020	Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial.
4/2019	Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.
1/2018	Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches.
1/2017	Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.
1/2015	The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.
1/2015	A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
9/2014	Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c mice.
6/2014	Structure-activity relationship of 1-desamino-8-D-arginine vasopressin as an antiproliferative agent on human vasopressin V2 receptor-expressing cancer cells.
11/2013	Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
1/2013	Implication of von Willebrand factor as a regulator of tumor cell metastasis: potential perioperative use of desmopressin and novel peptide analogs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giselle V Ripoll Research Topics

Disease

20	Neoplasms (Cancer) 10/2020 - 09/2002
11	Neoplasm Metastasis (Metastasis) 04/2019 - 09/2002
11	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2002
6	Hemorrhage 10/2020 - 09/2002
6	Carcinoma (Carcinomatosis) 04/2019 - 09/2002
4	Melanoma (Melanoma, Malignant) 12/2006 - 12/2002
3	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2017
3	Experimental Melanoma 11/2006 - 12/2002
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 01/2017
2	Residual Neoplasm 09/2008 - 12/2006
2	Lymphatic Metastasis 11/2006 - 09/2002
1	Rectal Neoplasms (Rectal Cancer) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Circulating Neoplastic Cells 01/2015
1	Carcinogenesis 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Colonic Neoplasms (Colon Cancer) 12/2010
1	Ascites 12/2010
1	Hypersensitivity (Allergy) 12/2006
1	Disease Susceptibility (Diathesis) 02/2006
1	Histiocytosis 09/2002

Drug/Important Bio-Agent (IBA)

17	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2020 - 09/2002
14	Vasopressins (Vasopressin)IBA 10/2020 - 09/2002
8	Peptides (Polypeptides)IBA 04/2019 - 09/2008
7	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2019 - 11/2006
4	Hemostatics (Antihemorrhagics)IBA 10/2020 - 09/2002
3	Arginine Vasopressin (Argipressin)IBA 04/2019 - 10/2008
3	von Willebrand FactorIBA 01/2015 - 11/2006
2	Complement System Proteins (Complement)IBA 04/2019 - 01/2016
2	Cytostatic AgentsIBA 01/2018 - 01/2015
2	Carmustine (FIVB)FDA Link 01/2016 - 09/2008
2	valyl(4)-glutaminyl(5)- desmopressinIBA 01/2016 - 12/2011
2	VaccinesIBA 12/2006 - 12/2002
2	Tissue Inhibitor of Metalloproteinase-1IBA 11/2006 - 01/2003
1	SynaptophysinIBA 01/2017
1	Chromogranin AIBA 01/2017
1	NeuropeptidesIBA 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2017
1	Cytotoxins (Cytolysins)IBA 01/2016
1	Hormones (Hormone)IBA 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Keratin-19 (Keratin 19)IBA 01/2015
1	ElementsIBA 01/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2014
1	AnticoagulantsIBA 09/2014
1	Tranexamic Acid (AMCA)FDA Link 09/2014
1	Cell Surface ReceptorsIBA 06/2014
1	Alanine (L-Alanine)FDA Link 06/2014
1	Amino Acids FDA Link 06/2014
1	PlasminogenIBA 11/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2013
1	AngiostatinsIBA 11/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2012
1	Estrogens (Estrogen)FDA Link 01/2012
1	EnzymesIBA 01/2012
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2012
1	Doxycycline (Periostat)FDA LinkGeneric 01/2012
1	Arachidonic Acid (Vitamin F)IBA 01/2012
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2012
1	Complementary DNA (cDNA)IBA 01/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2012
1	Valine (L-Valine)FDA Link 12/2011
1	Glutamine (L-Glutamine)FDA Link 12/2011
1	CytokinesIBA 12/2006
1	Factor VIII (Coagulation Factor VIII)IBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	G(M3) GangliosideIBA 12/2002
1	GangliosidesIBA 12/2002
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 10/2020 - 09/2008
4	Therapeutics 01/2016 - 11/2006
2	Operative Surgical Procedures 01/2015 - 12/2010
2	Intravenous Administration 11/2013 - 09/2008
1	Radiotherapy 10/2020
1	Castration 01/2019
1	Intravenous Infusions 01/2015
1	Intravenous Injections 11/2006